Ammonium Sulfate Expansion And Tax Credits Will Strengthen Future Earnings Stability

AN
AnalystConsensusTarget
Consensus Narrative from Analysts
Published
24 Sep 24
Updated
28 May 25
AnalystConsensusTarget's Fair Value
US$33.14
43.7% undervalued intrinsic discount
28 May
US$18.66
Loading
1Y
-34.4%
7D
-12.1%

Author's Valuation

US$33.1

43.7% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 12%

AnalystConsensusTarget has decreased revenue growth from 5.1% to 4.4%.

Shared on02 Apr 25
Fair value Increased 2.45%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 5.06%

AnalystConsensusTarget has decreased revenue growth from 5.7% to 5.1%, decreased profit margin from 10.6% to 8.9% and increased future PE multiple from 6.8x to 7.8x.

Shared on11 Mar 25
Fair value Increased 12%

AnalystConsensusTarget has increased revenue growth from 4.7% to 5.7%.